- Home
- GMM vs MNOV Comparison
GMM vs MNOV Comparison
Compare GMM & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- MNOV
- Stock Information
- Founded
- GMM 2017
- MNOV 2000
- Country
- GMM China
- MNOV United States
- Employees
- GMM N/A
- MNOV N/A
- Industry
- GMM
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- MNOV Health Care
- Exchange
- GMM Nasdaq
- MNOV Nasdaq
- Market Cap
- GMM 70.8M
- MNOV 67.2M
- IPO Year
- GMM 2023
- MNOV 2005
- Fundamental
- Price
- GMM $2.79
- MNOV $1.41
- Analyst Decision
- GMM
- MNOV Strong Buy
- Analyst Count
- GMM 0
- MNOV 1
- Target Price
- GMM N/A
- MNOV $9.00
- AVG Volume (30 Days)
- GMM 25.2K
- MNOV 11.2K
- Earning Date
- GMM 06-10-2025
- MNOV 05-13-2025
- Dividend Yield
- GMM N/A
- MNOV N/A
- EPS Growth
- GMM 62.17
- MNOV N/A
- EPS
- GMM 6.37
- MNOV N/A
- Revenue
- GMM $41,360,953.00
- MNOV N/A
- Revenue This Year
- GMM N/A
- MNOV N/A
- Revenue Next Year
- GMM N/A
- MNOV N/A
- P/E Ratio
- GMM $0.44
- MNOV N/A
- Revenue Growth
- GMM 53.82
- MNOV N/A
- 52 Week Low
- GMM $1.69
- MNOV $1.12
- 52 Week High
- GMM $15.60
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- GMM 51.23
- MNOV 47.51
- Support Level
- GMM $2.64
- MNOV $1.38
- Resistance Level
- GMM $2.99
- MNOV $1.45
- Average True Range (ATR)
- GMM 0.31
- MNOV 0.07
- MACD
- GMM 0.02
- MNOV 0.00
- Stochastic Oscillator
- GMM 51.72
- MNOV 54.55
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.